|
|
 |
VIZAMYL Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VABOMERE Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ALUMINUM OXIDE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ASCORBIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VEREGEN Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VANILLIN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ACACIA Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|